Related Experiment Video
Updated: May 20, 2026
08:55
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
Correlation between LRRK2 gene G2385R polymorphisms and Parkinson's disease
Huiru Yan1, Qingping Ma, Xinling Yang
1Neurology Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, PR China.
Molecular Medicine Reports
|July 31, 2012
Summary
The LRRK2 G2385R polymorphism
Area of Science:
- Genetics
- Neurology
- Population Studies
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder with complex etiology.
- Genetic factors, including LRRK2 gene variations, are implicated in PD pathogenesis.
- Understanding population-specific genetic risk factors is crucial for PD research.
Purpose of the Study:
- To investigate the association between the LRRK2 G2385R polymorphism and Parkinson's disease (PD).
- To compare the genotypic and allelic frequencies of this polymorphism between Uyghur and Han Chinese populations.
- To assess the risk of PD associated with the G2385R polymorphism in different ethnic groups and age strata.
Main Methods:
- Case-control study design.
- Analysis of LRRK2 gene G2385R polymorphism using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and DNA sequencing.
- Comparison of genotype and allele frequencies between PD patients and control groups, stratified by ethnicity and age.
Main Results:
- The GG genotype was most frequent; the AA genotype was absent. The GA genotype frequency was lowest.
- Han Chinese individuals with the GA genotype and A allele showed a higher risk of PD compared to controls.
- The GA genotype and A allele frequencies were significantly higher in Han Chinese PD patients than in Uyghur PD patients, indicating a higher PD risk in Han individuals carrying the A allele, especially those aged ≥50 years.
Conclusions:
- The LRRK2 G2385R polymorphism, specifically the A allele, is associated with an increased risk of Parkinson's disease.
- Significant differences in genotypic and allelic frequencies exist between Uyghur and Han Chinese populations regarding the LRRK2 G2385R polymorphism.
- The risk conferred by the A allele appears more pronounced in the Han Chinese population and in individuals aged 50 years and older.
Related Concept Videos
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...